Solid Pro-Nano Lipid Oral Formulations for Cannabidiol (CBD)
Pharmaceutics · 31.03.2026 · 18 (4) · 436
DOI: 10.3390/pharmaceutics18040436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 31.03.2026. Verfasst von Awanish Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Solid pro-nano lipid (SPNL) oral formulations were prepared and tested in rats for enhanced oral bioavailability of cannabidiol (CBD).
Methods
The solid formulation at room temperature is a uniform solution of CBD in a mixture of solid lipids and surfactants. Upon contact with aqueous media, it disperses into
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
- The Core Research Facility, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
- Jerusalem College of Technology (JCT), Machon Lev, Jerusalem 91160, Israel.
ORCID-Profile: Amnon Hoffman, Abraham J Domb
Zitieren
APA
Kumar, A., Bar-Hai, A., AbdEl-Haq, M., Gur, M., Hoffman, A., & Domb, A. J. (2026). Solid Pro-Nano Lipid Oral Formulations for Cannabidiol (CBD). Pharmaceutics, 18(4), 436. https://doi.org/10.3390/pharmaceutics18040436
Vancouver
Kumar A, Bar-Hai A, AbdEl-Haq M, Gur M, Hoffman A, Domb AJ. Solid Pro-Nano Lipid Oral Formulations for Cannabidiol (CBD). Pharmaceutics. 2026;18(4):436. doi:10.3390/pharmaceutics18040436
BibTeX
@article{Kumar2026,
author = {Kumar, Awanish and Bar-Hai, Ayala and AbdEl-Haq, Muhammad and Gur, Michal and Hoffman, Amnon and Domb, Abraham J},
title = {Solid Pro-Nano Lipid Oral Formulations for Cannabidiol (CBD)},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {4},
pages = {436},
doi = {10.3390/pharmaceutics18040436}
}
EUVIMED